• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Amedisys Shareholders Approve $3.3B UnitedHealth Union.

Share:

September 19, 2023

Amedisys shareholders have voted in favor of the approximately $3.3 billion acquisition by Optum, a UnitedHealth Group subsidiary. The approval includes the merger agreement adoption and executive officer compensation. However, the deal is still under review by the Department of Justice (DOJ). Amedisys filed merger notifications with the FTC and DOJ in July, with the DOJ requesting additional information. While shareholders are on board, finalization depends on approvals from state regulatory and government authorities. UnitedHealth Group’s acquisition of Amedisys is part of its strategic expansion in the home healthcare sector, following its acquisition of LHC Group earlier in the year.

Shareholders of healthcare-at-home specialist Amedisys voted in favor of the roughly $3.3 billion pending acquisition by Optum, a subsidiary of UnitedHealth Group, according to a Securities and Exchange Commission filing.

The shareholders approved the adoption of the merger agreement, as well as compensation to the company’s executive officers in connection with the merger.

Still, the deal continues to be under review by the Department of Justice.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Amedisys filed notifications of the merger with the Federal Trade Commission and Antitrust Division of the Department of Justice in July, and in an SEC filing last month said it received a request for additional information from the DOJ, extending the HSR Act waiting period until the parties have fulfilled the DOJ’s demands.

Though shareholders have approved the deal, its finalization is subject to approval from certain state regulatory and government authorities.

THE LARGER TREND

In June, UnitedHealth Group announced its plans to purchase the Louisiana-based home healthcare provider in an all-cash deal, beating out Option Care Health.

According to a May SEC filing, Option Care Health entered into an Agreement and Plan of Merger with the home health company in an all-stock offer, but just one month later entered into a termination agreement that included a termination fee of $106 million payable within 24 hours of the execution of the agreement.

In February, United Healthcare finalized its acquisition of another home health company, LHC Group, in a $5.4 billion deal, further expanding its reach in the home healthcare market.

Source: MobihealthNews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Cigna and Humana Merger Talks Could Face Antitrust ScrutinyCigna and Humana Merger Talks Could Face Antitrust Scrutiny
  • Wave Life Sciences Stock Soars on Weight Loss Drug DataWave Life Sciences Stock Soars on Weight Loss Drug Data
  • PathAI and Roche Team up to Push Adoption of Digital Pathology TechPathAI and Roche Team up to Push Adoption of Digital Pathology Tech
  • Circle Cardiovascular Imaging Announces Partnership with Dia Imaging Analysis to Deliver All-in-one Comprehensive Ai-based Cardiovascular Imaging SolutionsCircle Cardiovascular Imaging Announces Partnership with Dia Imaging Analysis to Deliver All-in-one Comprehensive Ai-based Cardiovascular Imaging Solutions
  • HealthEdge Acquires Wellframe to Enter Member Engagement MarketHealthEdge Acquires Wellframe to Enter Member Engagement Market
  • Apple Reportedly Looking to Expand Smartwatch Health Features to Blood Pressure and Fertility TrackingApple Reportedly Looking to Expand Smartwatch Health Features to Blood Pressure and Fertility Tracking
  • Japanese Medical AI Startup Ubie Snaps up $26M in Series C FundingJapanese Medical AI Startup Ubie Snaps up $26M in Series C Funding
  • Waltz Health | Redefining Medicare Drug AffordabilityWaltz Health | Redefining Medicare Drug Affordability

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications